Clinical Trials in Philadelphia

Showing 13621-13640 of 17,926 trials

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery

NCT02080689

The influence of Decipher test on urologist and patient treatment plan choices immediately post RP and at the time of PSA rise or BCR

Prostate Cancer

GenomeDx Biosciences Corp286 participantsStarted May 2014

Anchorage, Alaska, United States • Los Angeles, California, United States • Aurora, Colorado, United States +16 more locations

COMPLETEDPhase 3< 1 mile

Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass

NCT00048308

During a heart bypass procedure, a substance called "complement" is released by the body. This complement causes inflammation, which can lead to side effects such as chest pain, heart attacks, heart failure, or impairment of memory, language and motor skills. The purpose of this study is to find out if the study drug (pexelizumab), which blocks complement release, can reduce such side effects and be taken safely.

Cardio-pulmonary BypassCoronary Artery Bypass Graft

Alexion Pharmaceuticals, Inc.3,000 participantsStarted Jan 2002

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Mobile, Alabama, United States +183 more locations

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery

Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass

Find Trials by Condition in Philadelphia

Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer

Performance of PicoWayTM Picosecond Fractional Laser for Acne Scars

A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.

Naltrexone/Bupropion Cardiovascular Outcomes Study

The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial

Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Soft Tissue Open Surgeries

A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity

Collection of Samples From HIV-1 Infected Individuals for Evaluation of the Aptima HIV-1 Assay

Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA

Yoga in Treating Sleep Disturbance in Cancer Survivors

Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability

Safety of a Single Intravenous Dose of Recombinant Factor XIII in Children With Congenital FXIII A-subunit Deficiency

Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited Deficiency

Evaluation of the Efficacy and Safety of AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease

Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetes

Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) Patients

Safety & Efficacy of Certican in Pediatric de Novo Renal Transplant Patients

Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV